Personalized Cancer Vaccine NEO-PV-01 Shows Promise in 3 Types of Advanced Cancer
Early results from a clinical trial of personalized cancer vaccine NEO-PV-01 in 3 types of advanced cancer have shown promise and no significant toxicity issues.
Urologic Cancers
UROLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
Looking at Survival Differently in Patients With Metastatic Kidney Cancer
Conditional survival may more accurately assess prognosis than traditional survival for patients with metastatic kidney cancer, but the metric is not without its caveats. -
New Trial Attempts to Make Genetic Counseling and Testing More Accessible
The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.” -
T-Cell Cryopreservation for Use in Future Cancer Treatment: Hot or Hype?
Can healthy immune cells from a patient be frozen and used in the future to make adoptive cell therapies in the event of a cancer diagnosis? -
Do Oncologists Change Practice Based on Inadequate Evidence?
Oncologists are changing the way they treat, perhaps too quickly and with too little evidence — but the behavior may signal a bigger problem with how research is reported.
UROLOGIC CANCERS NEWS
Delayed RC for Histologic Variant Urothelial Bladder Cancer Ups Death Risk
Robotic, Open Cystectomy for Bladder Cancer Offer Comparable Outcomes
Right-Sided RCC Predicts Better Outcomes in Patients With Larger Tumors
Combo Shows Promise as Alternative for Metastatic Urothelial Carcinoma
UTUC With Isolated Lymph Node Involvement Predicts Poor Survival
Want to read more?
Please login or register first to view this content.
Next post in General Oncology
